What You Should Know:
- Cardinal Health today announced it has signed a definitive agreement to contribute its Outcomes™ business to Orlando-based Transaction Data Systems (TDS) in exchange for a minority stake in the combined entity.
- Under the terms of the merger agreement, Cardinal Health’s pharmaceutical segment CEO, Debbie Weitzman, will be appointed to the TDS board of directors.
- TDS’s existing portfolio of clinical pharmacy solutions includes the Rx30 and Computer-Rx pharmacy management systems and PrescribeWellness.
- Together, TDS and Outcomes will create additional opportunities for pharmacists to participate in sponsored clinical interventions and better access for payors and pharmaceutical companies to drive better care and outcomes for patients.
